Antiretroviral Treatment of Adult HIV Infection2010 Recommendations of the International AIDS Society–USA Panel
By M. Thompson, J. Aberg, H. Günthard. 2010
1,764 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/eed849cd62e0561119c968e578c5a2e682e4e57f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Maurizio Zazzi
- Michal Rosen-Zvi
- Mattia C. F. Prosperi
- S. Worm
- R. Weber
- C. Sabin
- R. Kaiser
- André Altmann
Citations in the corpus
- Decreases in Community Viral Load Are Accompanied by Reductions in New HIV Infections in San Francisco (2010, background): “The current new era of highly potent, tolerable ART,[23] coupled with recent advances in HIV testing technology and policy changes such as recommendations for routine testing, have increased the proportion of HIV-infected individuals who are aware of their diagnosis[24–26] and receiving ART [27–29].”
- Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study. (2010, background): “HIV treatment patterns are complex [44], and any analysis of treatment exposure in an observational study will always reflect a simplification of a more complex reality.”
- Antiretroviral Therapy Optimisation without Genotype Resistance Testing: A Perspective on Treatment History Based Models (2010, background): “In fact, current (2010) recommendations of the International AIDS Society-USA Panel [1] state that treatment history should be considered when designing a new regimen.”
- Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada (2013, background): “These findings may lend additional support to the earlier initiation of ART, in accordance with both the DHHS guidelines recommending universal therapy [30] and the 2012 International AIDS Society-USA (IAS-USA) guidelines, which recommend use of ART for all HIV-positive individuals regardless of CD4”